Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Hunault

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Scientific Reports|June 13, 2022
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AMLEmmanuel Gyan, Arnaud Pigneux, Mathilde Hunault, et al.
Haematologica|March 10, 2022
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALLAurelie Cabannes-Hamy, Eolia Brissot, Thibaut Leguay, et al.
Medicine|March 18, 2008
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patientsBenjamin Terrier, Arnaud Jaccard, Jean-Luc Harousseau, et al.
Leukemia|November 27, 2019
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantationAnne Bouvier, Jérémie Riou, Sylvain Thépot, et al.
Haematologica|December 16, 2017
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and <i>FLT3</i> internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Stroke|July 26, 2021
FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed InfarctionJuliette Tennenbaum, Matthieu Groh, Laura Venditti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroupThomas Prébet, Nicolas Boissel, Sarah Reutenauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2019
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALLAurore Touzart, Etienne Lengliné, Mehdi Latiri, et al.
Blood Advances|September 15, 2021
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO studyRaynier Devillier, Edouard Forcade, Alice Garnier, et al.
Leukemia|June 14, 2018
A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDSPierre Fenaux, Valeria Santini, Maria Antonietta Aloe Spiriti, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Scientific Reports|June 13, 2022
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AMLEmmanuel Gyan, Arnaud Pigneux, Mathilde Hunault, et al.
Haematologica|March 10, 2022
High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALLAurelie Cabannes-Hamy, Eolia Brissot, Thibaut Leguay, et al.
Medicine|March 18, 2008
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patientsBenjamin Terrier, Arnaud Jaccard, Jean-Luc Harousseau, et al.
Leukemia|November 27, 2019
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantationAnne Bouvier, Jérémie Riou, Sylvain Thépot, et al.
Haematologica|December 16, 2017
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and <i>FLT3</i> internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Stroke|July 26, 2021
FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed InfarctionJuliette Tennenbaum, Matthieu Groh, Laura Venditti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroupThomas Prébet, Nicolas Boissel, Sarah Reutenauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2019
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALLAurore Touzart, Etienne Lengliné, Mehdi Latiri, et al.
Blood Advances|September 15, 2021
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO studyRaynier Devillier, Edouard Forcade, Alice Garnier, et al.
Leukemia|June 14, 2018
A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDSPierre Fenaux, Valeria Santini, Maria Antonietta Aloe Spiriti, et al.
Pageof 13